The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010

S. E. Holden; A. H. Barnett; J. R. Peters; S. Jenkins-Jones; C. D. Poole; C. L. Morgan; C. J. Currie

doi:10.1111/dom.12123

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010

Diabetes Obesity and Metabolism ◽

10.1111/dom.12123 ◽

2013 ◽

Vol 15 (9) ◽

pp. 844-852 ◽

Cited By ~ 63

Author(s):

S. E. Holden ◽

A. H. Barnett ◽

J. R. Peters ◽

S. Jenkins-Jones ◽

C. D. Poole ◽

...

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

The United Kingdom

Download Full-text

1418-P: Increased Risk of Incident Heart Failure and All-Cause Mortality in Insulin-Resistant People with Type 2 Diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)

Diabetes ◽

10.2337/db20-1418-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 1418-P

Author(s):

MALGORZATA WAMIL ◽

RUTH L. COLEMAN ◽

AMANDA ADLER ◽

JOHN J. MCMURRAY ◽

RURY R. HOLMAN

Keyword(s):

Heart Failure ◽

Type 2 Diabetes ◽

United Kingdom ◽

Insulin Resistant ◽

The United Kingdom ◽

Increased Risk ◽

All Cause Mortality ◽

Incident Heart Failure

Download Full-text

PDB3 COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR COMPARED TO NPH INSULIN IN PATIENTS WITH TYPE-2 DIABETES IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)65946-3 ◽

2004 ◽

Vol 7 (6) ◽

pp. 735-736

Author(s):

I Smith ◽

AJ Palmer ◽

S Roze ◽

T Kennedy-Martin

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Detemir ◽

Cost Effectiveness Analysis ◽

Nph Insulin ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: changes over the period 2003‐2018

Diabetic Medicine ◽

10.1111/dme.14603 ◽

2021 ◽

Author(s):

Vanessa C Brunetti ◽

Oriana Hoi Yun Yu ◽

Robert W. Platt ◽

Kristian B. Filion

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

Subsequent Treatment ◽

Treatment Modification ◽

The United Kingdom

Download Full-text

The Cost-Effectiveness OF Canagliflozin (Cana) Versus Dapagliflozin (Dapa) In Patients With Type 2 Diabetes Mellitus (T2dm) With Inadequate Control On Metformin (Met) Monotherapy In The United Kingdom

Value in Health ◽

10.1016/j.jval.2014.08.694 ◽

2014 ◽

Vol 17 (7) ◽

pp. A344 ◽

Cited By ~ 2

Author(s):

M. Schroeder ◽

P. Johansen ◽

G. Thompson ◽

M. Willis ◽

C. Neslusan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

United Kingdom ◽

Cost Effectiveness ◽

The United Kingdom ◽

The Cost

Download Full-text

Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom

Primary Care Diabetes ◽

10.1016/j.pcd.2017.03.003 ◽

2017 ◽

Vol 11 (3) ◽

pp. 241-247 ◽

Cited By ~ 2

Author(s):

Daniel Sterzi ◽

Sébastien Auziere ◽

Divina Glah ◽

Marie Markert Jensen

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

General Practitioners ◽

Quantitative Study ◽

The United Kingdom

Download Full-text

TIME UNTIL INSULIN INITIATION FOR CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN DUAL AND TRIPLE THERAPY FOR TYPE 2 DIABETES MELLITUS IN THE UNITED KINGDOM

Value in Health ◽

10.1016/j.jval.2016.03.1317 ◽

2016 ◽

Vol 19 (3) ◽

pp. A198

Author(s):

M. Schroeder ◽

E. Chan ◽

M. Willis ◽

P. Johansen ◽

A. Nilsson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

United Kingdom ◽

Triple Therapy ◽

Insulin Initiation ◽

The United Kingdom

Download Full-text

Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

Cardiovascular Diabetology ◽

10.1186/1475-2840-7-24 ◽

2008 ◽

Vol 7 (1) ◽

pp. 24 ◽

Cited By ~ 27

Author(s):

Anette Woehl ◽

Mark Evans ◽

Anthony P Tetlow ◽

Philip McEwan

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

The United Kingdom ◽

The Cost

Download Full-text

Blood pressure control in type 2 diabetes—what does the United Kingdom prospective diabetes study (UKPDS) tell us?

Nephrology Dialysis Transplantation ◽

10.1093/ndt/14.11.2562 ◽

1999 ◽

Vol 14 (11) ◽

pp. 2562-2564 ◽

Cited By ~ 10

Author(s):

Rudy Bilous

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

United Kingdom ◽

Blood Pressure Control ◽

Pressure Control ◽

The United Kingdom

Download Full-text

The Cost-Effectiveness of Canagliflozin (CANA) Versus Dapagliflozin (Dapa) 10mg and Empagliflozin (EMPA) 25mg in Patients with Type 2 Diabetes Mellitus (T2DM) as Monotherapy in the United Kingdom

Value in Health ◽

10.1016/j.jval.2015.09.2098 ◽

2015 ◽

Vol 18 (7) ◽

pp. A607 ◽

Cited By ~ 4

Author(s):

M Schroeder ◽

P Johansen ◽

M Willis ◽

C Neslusan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

United Kingdom ◽

Cost Effectiveness ◽

The United Kingdom ◽

The Cost

Download Full-text

Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study

BMC Endocrine Disorders ◽

10.1186/1472-6823-11-17 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 9

Author(s):

Qiaoyi Zhang ◽

Elizabeth Marrett ◽

Kevin Jameson ◽

Susanne Meiler ◽

Michael J Davies ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

United Kingdom ◽

General Practitioners ◽

Older Patients ◽

Survey Study ◽

Newly Diagnosed ◽

The United Kingdom

Download Full-text